PortfoliosLab logoPortfoliosLab logo
ISIN
US59064R1095
CUSIP
59064R109
IPO Date
Jan 25, 1995

Highlights

Market Cap
$516.87M
Enterprise Value
$489.94M
EPS (TTM)
$1.21
PE Ratio
77.08
PEG Ratio
0.49
Total Revenue (TTM)
$249.13M
Gross Profit (TTM)
$158.27M
EBITDA (TTM)
$36.60M
Year Range
$55.45 - $113.99
Target Price
$94.00
ROA (TTM)
1.57%

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Mesa Laboratories, Inc.

Often compared with MLAB:
MLAB vs. VOOMLAB vs. SPY

Performance

MLAB Performance Chart

Mesa Laboratories, Inc. (MLAB) is up 19.2% since the beginning of the year. At $93 per share, MLAB is trading 18.2% below its 52-week high of $114. Investors who bought $1,000 worth of MLAB shares 5 years ago would now be looking at an investment worth $361.


Loading charts...

S&P 500 Index

Returns By Period

Mesa Laboratories, Inc. (MLAB) has returned 19.15% so far this year and -1.96% over the past 12 months. Over the last ten years, MLAB has returned -2.10% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.


Mesa Laboratories, Inc.

1D
-1.97%
1M
-14.05%
YTD
19.15%
6M
15.44%
1Y
-1.96%
3Y*
-9.25%
5Y*
-18.42%
10Y*
-2.10%

Benchmark (S&P 500 Index)

1D
-0.37%
1M
-0.01%
YTD
9.16%
6M
8.64%
1Y
25.22%
3Y*
19.78%
5Y*
11.99%
10Y*
13.88%
*Multi-year figures are annualized to reflect compound growth (CAGR)

MLAB Monthly Returns History

Based on dividend-adjusted daily data since Aug 18, 1995, MLAB's average daily return is +0.08%, while the average monthly return is +1.42%. At this rate, an investment would double in approximately 4.1 years.

Historically, 56% of months were positive and 44% were negative. The best month was Nov 2005 with a return of +39.2%, while the worst month was Sep 2023 at -26.7%. The longest winning streak lasted 9 consecutive months, and the longest losing streak was 7 months.

On a daily basis, MLAB closed higher 45% of trading days. The best single day was May 23, 2007 with a return of +22.6%, while the worst single day was Jun 3, 2019 at -25.7%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20260.33%22.82%-8.44%13.10%2.18%-8.62%19.15%
20254.41%1.35%-14.87%-2.87%-12.56%-6.36%-18.83%-11.20%-1.09%7.28%11.78%-2.12%-40.05%
2024-12.55%19.35%0.49%-3.33%-9.65%-9.33%31.98%16.88%-2.86%-12.18%2.86%12.57%26.56%
202317.04%-9.18%-1.01%-4.70%-22.14%-0.76%0.12%11.55%-26.71%-10.70%-8.85%22.72%-36.65%
2022-13.34%-10.14%-0.18%-16.18%-1.98%-2.54%4.57%-19.80%-17.58%-6.12%28.08%-1.75%-49.18%
2021-3.31%-1.83%-10.45%2.11%-0.98%10.20%8.61%-9.31%13.28%1.10%1.06%6.25%14.73%

Benchmark Metrics

Mesa Laboratories, Inc. has an annualized alpha of 18.00%, beta of 0.42, and R2 of 0.03 versus S&P 500 Index. Calculated based on daily prices since August 18, 1995.

  • This stock participates in less of S&P 500 Index's moves in both directions, but captures a larger share of gains (74.37%) than losses (54.62%) - typical of diversified or defensive assets.
  • Beta of 0.42 may look defensive, but with R2 of 0.03 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
  • R2 of 0.03 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
18.00%
Beta
0.42
0.03
Upside Capture
74.37%
Downside Capture
54.62%

Return for Risk

Risk / Return Rank

MLAB ranks 41 for risk / return — on par with similar stocks. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.


MLAB Risk / Return Rank: 4141
Overall Rank
MLAB Sharpe Ratio Rank: 4141
Sharpe Ratio Rank
MLAB Sortino Ratio Rank: 4141
Sortino Ratio Rank
MLAB Omega Ratio Rank: 4242
Omega Ratio Rank
MLAB Calmar Ratio Rank: 4040
Calmar Ratio Rank
MLAB Martin Ratio Rank: 4141
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Mesa Laboratories, Inc. (MLAB) and compare them to S&P 500 Index.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


MLABBenchmarkDifference
Sharpe ratioReturn per unit of total volatility

-2.06

Sortino ratioReturn per unit of downside risk

-2.36

Omega ratioGain probability vs. loss probability

1.06

1.37

-0.31

Calmar ratioReturn relative to maximum drawdown

-0.04

2.78

-2.83

Martin ratioReturn relative to average drawdown

-0.09

12.44

-12.53

Dividends

Dividend History

Mesa Laboratories, Inc. provided a 0.69% dividend yield over the last twelve months, with an annual payout of $0.64 per share. The company has been increasing its dividends for 18 consecutive years.


0.20%0.30%0.40%0.50%0.60%0.70%0.80%$0.00$0.10$0.20$0.30$0.40$0.50$0.6020152016201720182019202020212022202320242025
Dividends
Dividend Yield
PeriodTTM20252024202320222021202020192018201720162015
Dividend$0.64$0.64$0.64$0.64$0.64$0.64$0.64$0.64$0.64$0.64$0.64$0.64

Dividend yield

0.69%0.82%0.49%0.61%0.39%0.20%0.22%0.26%0.31%0.51%0.52%0.64%

Monthly Dividends

The table displays the monthly dividend distributions for Mesa Laboratories, Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026$0.00$0.16$0.00$0.00$0.16$0.00$0.32
2025$0.00$0.16$0.00$0.00$0.16$0.00$0.00$0.16$0.00$0.00$0.16$0.00$0.64
2024$0.00$0.16$0.00$0.00$0.16$0.00$0.00$0.16$0.00$0.00$0.16$0.00$0.64
2023$0.00$0.16$0.00$0.00$0.16$0.00$0.00$0.16$0.00$0.00$0.16$0.00$0.64
2022$0.00$0.16$0.00$0.00$0.16$0.00$0.00$0.16$0.00$0.00$0.16$0.00$0.64
2021$0.00$0.16$0.00$0.00$0.16$0.00$0.00$0.16$0.00$0.00$0.16$0.00$0.64

Dividend Yield & Payout


Dividend Yield

Mesa Laboratories, Inc. has a dividend yield of 0.69%, which signifies it pays a smaller percentage of its stock price in dividends to its shareholders compared to other companies in the market.

Payout Ratio

Mesa Laboratories, Inc. has a payout ratio of 52.28%, which is quite average when compared to the overall market. This suggests that Mesa Laboratories, Inc. strikes a balance between reinvesting profits for growth and paying dividends to shareholders.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the Mesa Laboratories, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Mesa Laboratories, Inc. was 82.43%, occurring on Aug 5, 2025. The portfolio has not yet recovered.

The current Mesa Laboratories, Inc. drawdown is 71.27%.


Related event

Drawdown

Fall

Recovery

Underwater

2025 bear market2025
-82.43%Aug 2025
3y 7mo
4y 5moDec 2021 - now
2000 bear market2000
-64.81%Feb 2000
3y 8mo3y 10mo
7y 6moJun 1996 - Dec 2003
Financial crisis2007–2009
-43.70%Mar 2009
1y 2mo9mo 9d
1y 11moJan 2008 - Dec 2009
2014 bear market2014
-41.25%Sep 2014
6mo 3d10mo
1y 3moMar 2014 - Jul 2015
2016 bear market2016
-34.53%Feb 2016
6mo 9d3mo 28d
10mo 7dAug 2015 - Jun 2016

Drawdown Indicators


MLABBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-82.43%

-56.78%

-25.65%

Max Drawdown (1Y)

Largest decline over 1 year

-44.45%

-9.10%

-35.35%

Max Drawdown (3Y)

Largest decline over 3 years

-62.78%

-18.90%

-43.88%

Max Drawdown (5Y)

Largest decline over 5 years

-82.43%

-25.43%

-57.00%

Max Drawdown (10Y)

Largest decline over 10 years

-82.43%

-33.92%

-48.51%

Current Drawdown

Current decline from peak

-71.27%

-1.80%

-69.47%

Average Drawdown

Average peak-to-trough decline

-25.47%

-10.71%

-14.76%

Ulcer Index

Depth and duration of drawdowns from previous peaks

22.72%

2.03%

+20.69%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Mesa Laboratories, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Mesa Laboratories, Inc. is priced in the market compared to other companies in the Scientific & Technical Instruments industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio

The chart displays the Price-to-Earnings (P/E) ratio for MLAB, comparing it with other companies in the Scientific & Technical Instruments industry. Currently, MLAB has a P/E ratio of 77.1. This P/E ratio is significantly higher than those of industry peers. This could indicate that the stock is overvalued or that investors expect strong future growth.

PEG Ratio

The chart shows the Price/Earnings to Growth (PEG) ratio for MLAB compared to other companies in the Scientific & Technical Instruments industry. MLAB currently has a PEG ratio of 0.5. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for MLAB relative to other companies in the Scientific & Technical Instruments industry. Currently, MLAB has a P/S ratio of 2.1. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with MLAB

Add Mesa Laboratories, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with MLAB